NCT07474727 2026-03-16
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Multitude Therapeutics Inc.
Phase 2 Not yet recruiting
Multitude Therapeutics Inc.
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
Gruppo Oncologico del Nord-Ovest
Charite University, Berlin, Germany